Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Cyclo(L-Phe-L-Pro) | C14H16N2O2 | 3705-26-8 | Details |
| AQC | C14H11N3O4 | 148757-94-2 | Details |
| monoMICAAc | Details |
| 1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID | C13H13NO5 | 260555-42-8 | Details |
| 4-Methylumbelliferyl β-D-Galactopyranoside-6-sulfate (sodium salt) | C16H17NaO11S | 206443-06-3 | Details |
| Glucose oxidase | NULL | 9001-37-0 | Details |
| BGB-8035 | C24H31N5O4 | 2283349-24-4 | Details |
| Sitamaquine tosylate | C28H41N3O4S | 1019640-33-5 | Details |
| Osocimab | 2056878-75-0 | Details |
| mTOR/HDAC-IN-1 HCl | Details |
| Oxytocin C-terminal tripeptide Acetate | Details |
| BV02 | C20H15N3O5 | 292870-53-2 | Details |
| Betazole dihydrochloride | C5H11Cl2N3 | 138-92-1 | Details |
| Cyclohexanoyl Coenzyme A | C28H46N7O17P3S | 5960-12-3 | Details |
| Tetracosactide acetate | C138H214N40O33S | 60189-34-6 | Details |
| Midkine Protein, Chicken, Recombinant (His & Myc) | Details |
| Protirelin Acetate(24305-27-9 free base) | Details |
| Cefsulodin (sodium salt hydrate) | C22H23N4NaO9S2 | 1426397-23-0 | Details |
| KM 91104 | C14H12N2O4 | 304481-60-5 | Details |
| CYM5181 | C17H17N3O3 | 695155-81-8 | Details |
| ENPP2 Protein, Human, Recombinant (His) | Details |
| BAL-0028 | C24H22FN3O2 | 2842012-69-3 | Details |
| 1,5,7-Triazabicyclo[4.4.0]dec-5-ene | C7H13N3 | 5807-14-7 | Details |
| [4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine | C16H25N3O | 1157013-41-6 | Details |
| 1H-Pyrrolo[2,1-c][1,2,4]benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3aR)- | C10H12N2O2S | 175340-21-3 | Details |
| Nemazoline Free Base | C10H11Cl2N3 | 130759-56-7 | Details |
| ENPP3 Protein, Rhesus, Recombinant (His) | Details |
| Casein kinase 1δ-IN-14 | C17H11ClN4O2 | 793722-88-0 | Details |
| 2,6-Dibromophenol | C6H4Br2O | 608-33-3 | Details |
| IL-18R alpha Protein, Mouse, Recombinant (mFc) | Details |
| Interferon alpha 4/IFNA4 Protein, Human, Recombinant (His) | Details |
| HA5 | C15H10O5 | 2378406-17-6 | Details |
| 2-benzylsulfanyl-6-methoxy-4-methylquinazoline | C17H16N2OS | 500272-00-4 | Details |
| P8RI acetate | Details |
| Fanotaprim | C19H22N8O | 2120282-75-7 | Details |
| CDK1-IN-2 | C17H11ClN2O | 220749-41-7 | Details |
| Ac-DNLD-AMC | C30H38N6O12 | 958001-92-8 | Details |
| CAY10434 | C17H25N3O | 769917-29-5 | Details |
| TPO Protein, Human, Recombinant (His) | Details |
| (R)-Lisofylline | C13H20N4O3 | 100324-81-0 | Details |
| Plx-4032 | C23H18ClF2N3O3S | 1029872-54-5 | Details |
| Cochinchinenin A | C17H18O4 | 1057666-04-2 | Details |
| N-cis-hexadec-9Z-enoyl-L-Homoserine lactone | C20H35NO3 | 479050-94-7 | Details |
| Cholic Acid anilide | C30H45NO4 | 6912-96-5 | Details |
| Auristatin23 | C49H84N6O10 | 2375388-36-4 | Details |
| CL2A-SN-38 DCA 1279680-68-0(free base) | Details |
| Zelasudil | C22H21F2N7O | 2365193-22-0 | Details |
| HBDDE | C16H18O8 | 154675-18-0 | Details |
| JAMM protein inhibitor 2 | C21H26N2O2 | 848249-35-4 | Details |
| CID44216842 | C22H20BrN3O3S | 1222513-26-9 | Details |
| Necroptosis-IN-3 | C12H17NOS | 547698-18-0 | Details |
| Glymidine sodium | C13H14N3NaO4S | 3459-20-9 | Details |
| 9(S)-HETE | C20H32O3 | 107656-13-3 | Details |
| Testosterone phenylpropionate | C28H36O3 | 1255-49-8 | Details |
| Indirubin-3′-oxime | C16H11N3O2 | 667463-82-3 | Details |
| Complement C2 Protein, Human, Recombinant (His) | Details |
| G3335 Acetate | Details |
| MSA-2 | C14H14O5S | 129425-81-6 | Details |
| AM-8123 | C27H33N7O5S | 2049973-02-4 | Details |
| Ensituximab | 1092658-06-4 | Details |
| GSK251 | C29H37FN6O4S | 2125968-05-8 | Details |
| Atg4B-IN-2 | C21H30O3 | 2765008-88-4 | Details |
| A-971432 | C18H17Cl2NO3 | 1240308-45-5 | Details |
| Pratol | C16H12O4 | 487-24-1 | Details |
| Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)- | C24H23NO5S | 849150-59-0 | Details |
| N-trans-caffeoyltyramine | C17H17NO4 | 103188-48-3 | Details |
| Vixarelimab | 2243320-83-2 | Details |
| CK2α-IN-1 | C16H11N3O4S | 443747-52-2 | Details |
| CC-90001 | C16H27N5O2 | 1403859-14-2 | Details |
| Fosdevirine | C20H17ClN3O3P | 1018450-26-4 | Details |
| TR4161 | C20H36O4 | 21562-57-2 | Details |
| Hi 76-0079 | C11H13ClN2O3 | 374567-94-9 | Details |
| Tetrazolast | C10H6N8 | 95104-27-1 | Details |
| STK414603 | C11H9ClN2OS | 796115-75-8 | Details |
| USP1-IN-2 | C26H22F4N6O | 2098212-05-4 | Details |
| CHET3 | C21H21N5O3S | 2489231-47-0 | Details |
| Chlorin E6 | C34H36N4O6 | 19660-77-6 | Details |
| Plecanatide | C65H104N18O26S4 | 467426-54-6 | Details |
| RH01687 | C12 H9 Cl N6 O2 S | 302901-13-9 | Details |
| 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine | C13H16FN3O6 | 161599-46-8 | Details |
| N,N'-Dimethylthiourea | C3H8N2S | 534-13-4 | Details |
| AZD 3147 | C24H31N5O4S2 | 1101810-02-9 | Details |
| YS-121 | C20H26ClN3O2S | 916482-17-2 | Details |
| (R)-Enitociclib | C19H18F2N4O2S | 1610408-96-2 | Details |
| 14-Epiandrographolide | C20H30O5 | 142037-79-4 | Details |
| Indaconitine | C34H47NO10 | 4491-19-4 | Details |
| ML-148 | C20H21N3O | 451496-96-1 | Details |
| Simufilam dihydrochloride | C15H22ClN3O | 2480226-06-8 | Details |
| Ronacaleret HCl | C25H32ClF2NO4 | 702686-96-2 | Details |
| GPI-1485 | C12H19NO4 | 186268-78-0 | Details |
| EP4-IN-1 | C27H24N2O4 | 2455480-28-9 | Details |
| N-(4-Aminobenzoyl)-L-glutamic Acid (hydrate) | Details |
| Denzimol | C19H20N2O | 73931-96-1 | Details |
| 1-Octadecyl Lysophosphatidic Acid | C21H45O6P | 52977-29-4 | Details |
| 5,7-Diacetoxy-8-methoxyflavone | C20H16O7 | 23246-80-2 | Details |
| Fuzapladib | C15H20F3N3O3S | 141283-87-6 | Details |
| (rel)-PRT062607 | C19H23N9O | 1194954-52-3 | Details |
| 2-Bromohexadecanoic acid | C16H31BrO2 | 18263-25-7 | Details |
| Myristoyl Pentapeptide-17 Acetate | Details |
| (S)-Ebalzotan | 294843-95-1 | Details |
| Product Total： Product Page： | ||||
| 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 | ||||